Sanara MedTech Inc.

NASDAQ:SMTI

Medical - Instruments & Supplies

Healthcare
$32.73 +3.44%

+$0.73 today

Market cap
$300.55M
Beta
1.19
P/E (TTM)
-5.7
EPS (TTM)
-$3.86
52W Low $16.05High $35.95

Volume 0.07M

Average 0.06M

SMTI Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

Sanara MedTech Inc.NASDAQ: SMTI

Revenue · Q1 FY2026 · quarter ended Mar 2026

Revenue grows in line with its trailing trend

Q1 FY2026 revenue of $27.8M rose 18.6% year over year, ahead of the +17.4% change in trailing-twelve-month revenue. Sequentially, it rose 0.9% from the prior quarter. Over 3 fiscal years it compounded at +31.0% a year.

Context

  • Revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether revenue reaches the consensus estimate from 1 analysts of $115.3M (+11.8%) for the fiscal year ending Dec 2026, a slowdown from the +19.0% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$27.8M+0.9% QoQ
Last fiscal yearDec 2025
$103.12M+19.0% YoY
LTMMar 2026
$107.51M+17.4% YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+18.6%+12.1%-6.5 pp
1 year+19.0%+11.8%-7.2 pp
3-year CAGR+31.0%+12.0%-19.0 pp
5-year CAGR+12.9%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

USD · from the income statement

Latest · FY2025
103.12M USD
Year-over-year change
+19.0%
4-year CAGR
+43.8%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How SMTI compares with its peers on the latest reported figures

  • Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
  • Its year-over-year change of +17.4% is the 4th highest of 10, against a peer median of +11.2%.
  • Over three fiscal years its annual growth of +31.0% compares with a peer median of +13.0%.
SMTI Competitors
Revenue for SMTI and competitors
Company Period LTM YoY 3-year CAGR
NEONeoGenomics, Inc.LTM Jun 2026$766.3M USD+11.2%+12.6%
HITIHigh Tide Inc.LTM Apr 2026CA$671.57M CAD+22.0%+18.5%
TBRGTruBridge, Inc.LTM Mar 2026$345.9M USD-0.5%+2.0%
VMDViemed Healthcare, Inc.LTM Mar 2026$286.57M USD+23.1%+24.9%
LFMDLifeMD, Inc.LTM Mar 2026$219.42M USD-6.2%+17.7%
SMTISanara MedTech Inc.LTM Mar 2026$107.51M USD+17.4%+31.0%
SGHTSight Sciences, Inc.LTM Mar 2026$79.55M USD+1.8%+2.7%
XGNExagen Inc.LTM Mar 2026$68.38M USD+20.6%+13.5%
STXSStereotaxis, Inc.LTM Mar 2026$31.2M USD+13.4%+4.8%
TRDAEntrada Therapeutics, Inc.LTM Mar 2026$5.74M USD-96.7%—
Peer median (excluding SMTI) —+11.2%+13.0%

Competitors are the stored peer set for SMTI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue24.14M45.84M64.99M86.67M103.12M
Cost of Revenue2.31M6.36M7.85M8.14M10.18M
Gross Profit21.83M39.48M57.14M78.53M92.94M
Gross Margin90.4%86.1%87.9%90.6%90.1%
Research & Development558.7K3.37M4.13M5.7M5.07M
Selling, General & Admin28.05M45.98M56.99M76.56M78.72M
Operating Expenses29.21M52M61.35M85.25M83.79M
Depreciation & Amortization771.93K2.37M3.68M4.92M2.66M
EBITDA(7.22M)(11.57M)(289.1K)(1.86M)9.03M
EBITDA Margin-29.9%-25.2%-0.4%-2.1%8.8%
Operating Income(7.38M)(12.52M)(4.22M)(6.72M)9.15M
Operating Margin-30.6%-27.3%-6.5%-7.7%8.9%
Interest Income0284.75K021.98K3.67K
Interest Expense711284.75K475.78K3.13M6.76M
Other Income / Expenses(617.64K)(1.42M)(224.75K)(3.2M)(9.54M)
Income Before Tax(7.99M)(13.94M)(4.44M)(9.91M)(393.12K)
Pre-Tax Margin-33.1%-30.4%-6.8%-11.4%-0.4%
Income Tax Expense0(5.84M)000
Net Income(7.92M)(7.94M)(4.3M)(9.66M)(37.56M)
Net Margin-32.8%-17.3%-6.6%-11.2%-36.4%
EPS (Basic)(1.08)(1.00)(0.52)(1.14)(4.36)
EPS (Diluted)(1.08)(1.00)(0.52)(1.14)(4.36)
Weighted Avg Shares7.34M7.91M8.28M8.48M8.62M
Weighted Avg Shares (Diluted)7.34M7.91M8.28M8.48M8.62M

Sanara MedTech Inc.

NASDAQ:SMTI

Intrinsic Alpha fair value

Locked

Current Price

$32.73

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.